SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): July 7, 2008
GEOVAX LABS, INC.
(Exact name of registrant as specified in Charter)
| |
|
|
|
|
| Illinois
|
|
000-52091
|
|
87-0455038 |
| (State or other jurisdiction of
|
|
(Commission File No.)
|
|
(IRS Employee Identification No.) |
| incorporation or organization) |
|
|
|
|
1256 Briarcliff Road N.E.
Emtech Bio Suite 500
Atlanta, Georgia 30306
(Address of Principal Executive Offices)
(404) 727-0971
(Issuer Telephone number)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the Registrant under any of the following provisions (see General Instruction
A.2 below).
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR240.14a-12) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b)). |
| |
| o |
|
Pre-commencement communications pursuant to Rule 13e-4© under the Exchange Act (17 CFR
240.13(e)-4(c)) |
This Form 8-K and other reports filed by GeoVax Labs, Inc. (the “registrant”) from time to
time with the Securities and Exchange Commission (collectively the “Filings”) contain forward
looking statements and information that are based upon beliefs of, and information currently
available to, the registrant’s management as well as estimates and assumptions made by the
registrant’s management. When used in the Filings the words “anticipate”, “believe”, “estimate”,
“expect”, “future”, “intend”, “plan” or the negative if these terms and similar expressions as they
relate to the registrant or the registrant’s management identify forward looking statements. Such
statements reflect the current view of the registrant with respect to future events and are subject
to risks, uncertainties, assumptions and other factors relating to the registrant’s industry,
operations and results of operations and any businesses that may be acquired by the registrant.
Should one or more of these risks or uncertainties materialize, or should the underlying
assumptions prove incorrect, actual results may differ significantly from those anticipated,
believed, estimated, expected, intended or planned.
Item 8.01 Other Events
On July 7, 2008 we issued a press release providing an update on our vaccine development
activities. A copy of the press release is attached to this Current Report.
Item 9.01 Financial Statements and Exhibits
Exhibit 99.1 Press Release
2 of 3